The Financial Implications of Pancreas Transplant Complications

  • J. A. Cohn
  • M. J. Englesbe
Reference work entry


Diabetes mellitus is associated with profound morbidity and mortality. For a small subset of diabetics,  pancreas transplantation offers a cure for diabetes. Unfortunately, pancreas transplantation is associated with its own risks. These risks include  graft thrombosis and peri-operative infections in the short-term, and renal failure, malignancy, and infections related to the long-term effects of immunosuppression ( immunosuppression medications). Surgical complications of pancreas transplantation are associated with significant costs for the patient, the payer, the hospital, and the physician. For example, a patient with a surgical complication following pancreas transplantation will cost an insurer an additional $17,363. Quantifying the costs of surgical complications is important as payers and hospitals consider future investment in  quality improvement initiatives. Our work in pancreas transplantation suggests that payers bear the majority of the financial burden of pancreas transplant complications. Within this context, focused quality improvement initiatives in pancreas transplantation seem like a reasonable investment for large payers, such as  Medicare.


Surgical Complication Pancreas Transplant Quality Improvement Initiative Pancreas Allograft Enteric Drainage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:


blue cross and blue shield of Michigan


pancreas after kidney transplant


pancreas transplant alone


quality improvement


simultaneous kidney-pancreas transplant


United States dollar


  1. International Pancreas Transplant Registry. (2007). Accessed 3/2008.
  2. Andreoni KA, Brayman KL, Guidinger MK, Sommers CM, Sung RS. (2007). Am J Transplant. 7: 1359–1375.PubMedCrossRefGoogle Scholar
  3. Arozullah AM, Daley J, Henderson WG, Khuri SF. (2000). Ann Surg. 232: 242–253.PubMedCrossRefGoogle Scholar
  4. Arozullah AM, Khuri SF, Henderson WG, Daley J. (2001). Ann Intern Med. 135: 847–857.PubMedGoogle Scholar
  5. Cohn JA, Englesbe MJ, Ads YM, Paruch JL, Pelletier SJ, Welling TH, Sonnenday CJ, Magee JC, Punch JD, Campbell DA Jr., Sung RS. (2007). Am J Transplant. 7: 1656–1660.PubMedCrossRefGoogle Scholar
  6. Danovitch GM, Cohen DJ, Weir MR, Stock PG, Bennett WM, Christensen LL, Sung RS. (2005). Am J Transplant. 5: 904–915.PubMedCrossRefGoogle Scholar
  7. Dimick JB, Chen SL, Taheri PA, Henderson WG, Khuri SF, Campbell DA Jr. (2004). J Am Coll Surg. 199: 531–537.PubMedCrossRefGoogle Scholar
  8. Dimick JB, Weeks WB, Karia RJ, Das S, Campbell DA Jr. (2006). J Am Coll Surg. 202: 933–937.PubMedCrossRefGoogle Scholar
  9. Englesbe MJ, Dimick J, Mathur A, Ads Y, Welling TH, Pelletier SJ, Heidt DG, Magee JC, Sung RS, Punch JD, Hanto DW, Campbell DA Jr. (2006a) Am J Transplant. 6: 2978–2982.PubMedCrossRefGoogle Scholar
  10. Englesbe MJ, Dimick JB, Sonnenday CJ, Share DA, Campbell DA Jr. (2007). Ann Surg. 246: 1100–1103.PubMedCrossRefGoogle Scholar
  11. Englesbe MJ, Moyer A, Kim DY, Granger DK, Pietroski R, Yoshida A, Arenas JD, Oh H, Pelletier SJ, Campbell DA Jr., Punch JD, Magee JC, Gruber SA, Sung RS. (2006b). Transplantation. 82: 136–139.PubMedCrossRefGoogle Scholar
  12. Mitka M. (2007). Jama. 297: 2337–2338.PubMedCrossRefGoogle Scholar
  13. Sutherland DE, Gruessner RW, Dunn DL, Matas AJ, Humar A, Kandaswamy R, Mauer SM, Kennedy WR, Goetz FC, Robertson RP, Gruessner AC, Najarian JS. (2001). Ann Surg. 233: 463–501.PubMedCrossRefGoogle Scholar
  14. Troppmann C, Gruessner AC, Dunn DL, Sutherland DE, Gruessner RW. (1998). Ann Surg. 227: 255–268.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • J. A. Cohn
    • 1
  • M. J. Englesbe
    • 1
  1. 1.University of Michigan Health SystemAnn ArborMI

Personalised recommendations